- Home
- BNT vs HOLX Comparison
BNT vs HOLX Comparison
Compare BNT & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNT
- HOLX
- Stock Information
- Founded
- BNT 2020
- HOLX 1985
- Country
- BNT Bermuda
- HOLX United States
- Employees
- BNT N/A
- HOLX 7063
- Industry
- BNT
- HOLX Medical Electronics
- Sector
- BNT
- HOLX Health Care
- Exchange
- BNT Nasdaq
- HOLX Nasdaq
- Market Cap
- BNT 15.0B
- HOLX 14.8B
- IPO Year
- BNT N/A
- HOLX 1990
- Fundamental
- Price
- BNT $65.56
- HOLX $66.73
- Analyst Decision
- BNT
- HOLX Buy
- Analyst Count
- BNT 0
- HOLX 13
- Target Price
- BNT N/A
- HOLX $76.27
- AVG Volume (30 Days)
- BNT 8.0K
- HOLX 1.8M
- Earning Date
- BNT 08-07-2025
- HOLX 07-30-2025
- Dividend Yield
- BNT 0.55%
- HOLX N/A
- EPS Growth
- BNT N/A
- HOLX N/A
- EPS
- BNT 2.78
- HOLX 2.41
- Revenue
- BNT $14,371,000,000.00
- HOLX $4,038,900,000.00
- Revenue This Year
- BNT N/A
- HOLX $3.12
- Revenue Next Year
- BNT N/A
- HOLX $4.88
- P/E Ratio
- BNT $23.50
- HOLX $27.60
- Revenue Growth
- BNT 57.06
- HOLX 1.29
- 52 Week Low
- BNT $43.69
- HOLX $51.90
- 52 Week High
- BNT $68.87
- HOLX $84.39
- Technical
- Relative Strength Index (RSI)
- BNT 52.17
- HOLX 48.74
- Support Level
- BNT $63.07
- HOLX $66.67
- Resistance Level
- BNT $66.02
- HOLX $68.47
- Average True Range (ATR)
- BNT 0.82
- HOLX 1.14
- MACD
- BNT -0.15
- HOLX -0.27
- Stochastic Oscillator
- BNT 76.62
- HOLX 14.29
About BNT Brookfield Wealth Solutions Ltd.
Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. It is organized into three reporting segments: Direct Insurance, Reinsurance, and Pension Risk Transfer (PRT).
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.